Infectious Disease Treatments Market

ID: MRFR/Pharma/1095-HCR

90 Pages

Kinjoll Dey

October 2025

Infectious Disease Treatments Market Research Report Information By Type (Viral Diseases, Bacterial Diseases) Treatment (Antibacterial, Antifungal Drugs, Antiviral Drugs) End Users (Hospitals & Clinics, Retail Pharmacies) - Forecast till 2032

Infectious Disease Treatments Market Infographic

Single User

Multiple License

Enterprise User

Summary Table of Contents Segmentation Download PDF

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Certified Researchers

Customize Report

Infectious Disease Treatments Market Summary

As per Market Research Future Analysis, the Infectious Disease Treatments Market was valued at USD 58.02 Billion in 2023 and is projected to grow to USD 116.83 Billion by 2032, with a CAGR of 7.11% from 2024 to 2032. The market growth is driven by the increasing prevalence of infectious diseases such as tuberculosis (TB) and HIV/AIDS, alongside rising healthcare expenditures and patient awareness. However, challenges such as low treatment adoption and healthcare spending in developing economies may hinder growth. The market is segmented by type, treatment, and end users, with significant contributions from both viral and bacterial disease treatments. The Americas lead the market, followed by Europe and the Asia Pacific, which is the fastest-growing region.

Key Market Trends & Highlights

Key trends influencing the Infectious Disease Treatments Market include rising disease prevalence and advancements in treatment options.

Market Size in 2023: USD 58.02 Billion
Projected Market Size by 2032: USD 116.83 Billion
CAGR from 2024 to 2032: 7.11%
Major infectious diseases driving growth include TB and HIV/AIDS.

Infectious Disease Treatments Market

CAGR

7.11%

Market Size & Forecast

2023 Market Size	USD 58.02 Billion
2024 Market Size	USD 62.94 Billion
2032 Market Size	USD 116.83 Billion

Major Players

Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), GlaxoSmithKline plc. (U.K), AstraZeneca (U.K), Novartis AG (Switzerland), Sanofi (France), Mylan N.V. (U.S.)

Infectious Disease Treatments Market Drivers

Rising Incidence of Infectious Diseases

The Global Infectious Disease Treatments Market Industry is experiencing a notable surge due to the increasing incidence of infectious diseases worldwide. Factors such as urbanization, climate change, and global travel contribute to the spread of pathogens, leading to higher demand for effective treatments. For instance, the World Health Organization reports that infectious diseases account for a significant portion of global morbidity and mortality. This growing burden is projected to drive the market value to approximately 62.9 USD Billion in 2024, highlighting the urgent need for innovative therapeutic solutions.

Key Companies in the Infectious Disease Treatments Market market include

Future Outlook

Infectious Disease Treatments Market Future Outlook

The Infectious Disease Treatments Market is projected to grow at a 7.78% CAGR from 2024 to 2035, driven by advancements in biotechnology, rising global health awareness, and increasing prevalence of infectious diseases.

New opportunities lie in:

Invest in personalized medicine approaches to enhance treatment efficacy for specific infectious diseases. Develop innovative delivery systems for vaccines to improve accessibility and patient compliance. Leverage artificial intelligence for rapid drug discovery and development processes.

By 2035, the market is expected to be robust, reflecting substantial advancements and increased investment in infectious disease treatments.

Market Segmentation

Infectious Disease Treatments Market Segmentation

Key players for infectious disease treatments market
(U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
Pfizer Inc. (U.S.)
GlaxoSmithKline plc. (U.K)
(U.K)
Novartis AG (Switzerland)
Sanofi (France)
Mylan N.V. (U.S.)

Report Scope

Report Attribute/Metric	Details
Market Size 2023	58.02 (USD Billion)
Market Size 2024	62.94 (USD Billion)
Market Size 2032	116.83 (USD Billion)
Compound Annual Growth Rate (CAGR)	7.11 % (2024 - 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2024 - 2032
Historical Data	2019 - 2023
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), GlaxoSmithKline plc. (U.K), AstraZeneca (U.K), Novartis AG (Switzerland), Sanofi (France), Mylan N.V. (U.S.), and others
Key Market Opportunities	Increasing healthcare expendituresGrowing awareness of the patients
Key Market Drivers	Increasing prevalence of the infectious diseases

Market Highlights

Infectious Disease Treatments Companies

Author

Kinjoll Dey

Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

What was the market size of the Infectious Disease Treatments Market in 2023?

The Infectious Disease Treatments Market size was valued at USD 58.02 Billion in 2023.

What is the projected market size of the Infectious Disease Treatments Market by 2032?

The market is projected to grow to USD 116.83 Billion by 2032.

What is the compound annual growth rate (CAGR) of the market during the forecast period (2024-2032)?

The compound annual growth rate (CAGR) of the market is 7.11% during the forecast period.

How is the market segmented on the basis of type?

The market is segmented into viral diseases, bacterial diseases, and others. Viral diseases are further sub-segmented into AIDS, hepatitis B, hepatitis C, and others. Bacterial diseases are sub-segmented into tuberculosis (TB), bacterial meningitis, and others.

Which region dominates the infectious disease treatments market and why?

The Americas dominate the market due to a well-developed healthcare sector, a large patient population, increasing healthcare expenditure, changing lifestyles, and the presence of major players like Merck & Co., Inc., and Pfizer Inc.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027